BG
EIGR

Bellevue Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bellevue Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-111
Closed -$39K – 135
2016
Q4 		$39K Hold
111
– – 0.01% 122
2016
Q3 		$45K Hold
111
– – 0.01% 121
2016
Q2 		$66K Hold
111
– – 0.01% 124
2016
Q1 		$56K Buy
+111
New +$56K 0.01% 128